Daré Bioscience's market cap is currently $27.49M. The company's EPS TTM is $-0.441; its P/E ratio is ―; Daré Bioscience is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.81M	$ 10.00M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 2.77M	$ 9.95M	$ -26.41K	$ -43.23K	$ -11.14K
Operating Income	$ -30.84M	$ -31.39M	$ -39.07M	$ -27.40M	$ -14.34M
EBITDA	$ -30.90M	$ -31.36M	$ -39.04M	$ -27.36M	$ -14.33M
Net Income	$ -30.16M	$ -30.95M	$ -38.33M	$ -27.40M	$ -14.26M
Balance Sheet
Cash & Short-Term Investments	$ 10.48M	$ 34.67M	$ 51.67M	$ 4.67M	$ 4.78M
Total Assets	$ 21.28M	$ 43.83M	$ 55.81M	$ 7.55M	$ 7.44M
Total Debt	$ 1.40M	$ 488.74K	$ 270.55K	$ 756.84K	$ 800.45K
Net Debt	$ -9.07M	$ -34.18M	$ -51.40M	$ -3.91M	$ -3.98M
Total Liabilities	$ 26.33M	$ 32.71M	$ 17.05M	$ 8.70M	$ 7.00M
Stockholders' Equity	$ -5.05M	$ 11.11M	$ 38.75M	$ -1.15M	$ 440.83K
Cash Flow
Free Cash Flow	$ -39.49M	$ -18.15M	$ -28.78M	$ -25.25M	$ -13.32M
Operating Cash Flow	$ -38.86M	$ -18.09M	$ -28.76M	$ -25.23M	$ -13.32M
Investing Cash Flow	$ -629.43K	$ -63.07K	$ -14.52K	$ -17.63K	$ 6.14M
Financing Cash Flow	$ 15.64M	$ 1.34M	$ 75.85M	$ 25.13M	$ 5.15M

Currency in USD

Daré Bioscience Earnings and Revenue History

Income Statement >

Daré Bioscience Debt to Assets

Balance Sheet >

Daré Bioscience Cash Flow

Cash Flow >

Daré Bioscience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing